Published by Reclia Safety Desk | July 23, 2026
🚨 Recall Alert
Product: Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, Loxoprofen Na Tape 100mg ‘Sanwa’
Brand: Sanwa Chemical Research Institute
Hazards: Safety Risk
Case #00000035559 | View original notice ->
📋 Inscription Fact Summary
Product: Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, Loxoprofen Na Tape 100mg ‘Sanwa’
Brand: Sanwa Chemical Research Institute
Case Number: #00000035559
Recall Information Record
Case Number: 00000035559
Product: Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, Loxoprofen Na Tape 100mg ‘Sanwa’
Brand: Sanwa Chemical Research Institute
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)
WHAT HAPPENED
Sanwa Chemical Research Institute has issued a voluntary recall for four of its topical analgesic tape products: Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, and Loxoprofen Na Tape 100mg ‘Sanwa’. The recall was initiated after it was confirmed that manufacturing and process control were carried out in a manner inconsistent with the approved content, and that there were deficiencies in record-keeping.
This recall matters because the products are widely used for pain relief, and deviations from approved manufacturing procedures may affect the quality, safety, or efficacy of the medications. The Japan Consumer Affairs Agency (CAA) has published this notice under management number 00000035559, referencing the PMDA as the source of further information.
Users who have purchased these products should take the following steps:
- Check the product name and packaging to confirm if you have any of the affected items: Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, or Loxoprofen Na Tape 100mg ‘Sanwa’.
- Discontinue use immediately and contact Sanwa Chemical Research Institute or the point of purchase for instructions on return and refund.
- For further details, refer to the PMDA website or contact the Consumer Affairs Agency using the management number 00000035559.
AFFECTED BATCHES & TARGET SPECIFICS
– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A
ADDITIONAL REGULATORY NOTES
Recall initiated on 2026-07-14. Reason: Manufacturing and process control were conducted in a manner inconsistent with the approved content, and record-keeping deficiencies were confirmed. Reference source: PMDA. Management number: 00000035559.
❓ Frequently Asked Questions
Q: Which Sanwa Chemical Research Institute products are affected by this safety list?
A: The recall covers specific batches of Diclofenac Sodium Tape 15mg ‘Sanwa’, Diclofenac Sodium Tape 30mg ‘Sanwa’, Loxoprofen Na Tape 50mg ‘Sanwa’, Loxoprofen Na Tape 100mg ‘Sanwa’. Refer to official dossier #00000035559 for verified metrics.
Q: What physical hazard does this present?
A: Identified hazard vectors include: Safety Risk.
Q: What actions should affected users take?
A: Stop using the unit immediately. Follow official safety guidelines: View original CAA notice.
Disclaimer: Information on this page is summarized from official Japan Consumer Affairs Agency (CAA) recall notices.
Consumers should refer to the original Japan CAA notice for complete details.